Volume 17, Number 11—November 2011
THEME ISSUE
CHOLERA IN HAITI
Research
Characterization of Toxigenic Vibrio cholerae from Haiti, 2010–2011
Table 3
PFGE types
|
No. (%) isolates
| ||||||||||
All
|
2010 Oct 26
|
2010 Nov 26
|
2011 Jan 27
|
2011 Feb 9
|
Artibonite only
|
|
West Department only
| ||||
2010 Oct 26
|
2010 Nov 26
|
2010 Nov 26
|
2011 Jan 27
|
2011 Feb 9
| |||||||
SfiI types | |||||||||||
KZGS12.0088 | 130 (87.2) | 16 (100) | 76 (82.6) | 27 (90.0) | 11 (100) | 16 (100) | 16 (84.2) | 35 (81.4) | 21 (87.5) | 8 (100) | |
KZGS12.0089 | 8 (5.4) | 0 | 8 (8.7) | 0 | 0 | 0 | 2 (10.5) | 3 (7.0) | 0 | 0 | |
KZGS12.0097† | 7 (4.7) | 0 | 4 (4.3) | 3 (10.0) | 0 | 0 | 0 | 3 (7.0) | 3 (12.5) | 0 | |
KZGS12.0063† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
KZGS12.0158† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 1 (5.3) | 0 | 0 | 0 | |
KZGS12.0159† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 1 (2.3) | 0 | 0 | |
KZGS12.0160† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 1 (2.3) | 0 | 0 | |
NotI types | |||||||||||
KZGN11.0092 | 137 (91.9) | 15 (93.8) | 85 (92.4) | 26 (86.7) | 11 (100) | 15 (93.8) | 19 (100) | 36 (83.7) | 21 (87.5) | 8 (100) | |
KZGN11.0034† | 5 (3.4) | 1 (6.3) | 4 (4.3) | 0 | 0 | 1 (6.3) | 0 | 4 (9.3) | 0 | 0 | |
KZGN11.0142† | 4 (2.7) | 0 | 0 | 4 (13.3) | 0 | 0 | 0 | 0 | 3 (12.5) | 0 | |
KZGN11.0124† | 2 (1.3) | 0 | 2 (2.2) | 0 | 0 | 0 | 0 | 2 (4.7) | 0 | 0 | |
KZGN11.0134† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 1 (2.3) | 0 | 0 | |
SfiI/NotI combinations | |||||||||||
KZGS12.0088/KZGN11.0092 | 123 (82.6) | 15 (93.8) | 73 (79.3) | 24 (80.0) | 11 (100) | 15 (93.8) | 16 (84.2) | 32 (74.4) | 19 (79.2) | 8 (100) | |
KZGS12.0089/KZGN11.0092 | 8 (5.4) | 0 | 8 (8.7) | 0 | 0 | 0 | 2 (10.5) | 3 (7.0) | 0 | 0 | |
KZGS12.0097/KZGN11.0092† | 4 (2.7) | 0 | 2 (2.2) | 2 (6.7) | 0 | 0 | 0 | 1 (2.3) | 2 (8.3) | 0 | |
KZGS12.0088/KZGN11.0142† | 3 (2.0) | 0 | 0 | 3 (10.0) | 0 | 0 | 0 | 0 | 2 (8.3) | 0 | |
KZGS12.0088/KZGN11.0034† | 4 (2.7) | 1 (6.3) | 3 (3.3) | 0 | 0 | 1 (6.3) | 0 | 3 (7.0) | 0 | 0 | |
KZGS12.0097/KZGN11.0124† | 2 (1.3) | 0 | 2 (2.2) | 0 | 0 | 0 | 0 | 2 (4.7) | 0 | 0 | |
KZGS12.0063/KZGN11.0092† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
KZGS12.0097/KZGN11.0142† | 1 (0.7) | 0 | 0 | 1 (3.3) | 0 | 0 | 0 | 0 | 1 (4.2) | 0 | |
KZGS12.0158/KZGN11.0092† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 1 (5.3) | 0 | 0 | 0 | |
KZGS12.0159/KZGN11.0034† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 1 (2.3) | 0 | 0 | |
KZGS12.0160/KZGN11.0134† | 1 (0.7) | 0 | 1 (1.1) | 0 | 0 | 0 | 0 | 1 (2.3) | 0 |
0
*PFGE, pulsed-field gel electrophoresis.
*PFGE, pulsed-field gel electrophoresis.
*PFGE, pulsed-field gel electrophoresis. |
*PFGE, pulsed-field gel electrophoresis.
†Unique PFGE patterns first seen in this outbreak.
Page created: October 26, 2011
Page updated: October 27, 2011
Page reviewed: October 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.